Copy Link Print Information

NAD+

(Synonyms: β-DPN; β-NAD; β-Nicotinamide Adenine Dinucleotide)
51 Cited Publications
Revisión del cliente

Based on 51 publication(s) in Google Scholar

NAD+ is a coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.96%
  • No. CAS: 53-84-9
  • Fòrmula: C21H27N7O14P2
  • Peso molecular:663.43
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 1 year , -20°C, 6 months
  • NAD+ Chemical Structure
    NAD+ Chemical Structure
  • Experimental Validation Results for NAD+
  • Experimental Validation Results for NAD+
  • Experimental Validation Results for NAD+
  • Experimental Validation Results for NAD+
  • Experimental Validation Results for NAD+
  • Experimental Validation Results for NAD+
  • Experimental Validation Results for NAD+
  • Experimental Validation Results for NAD+
No. CAS: 53-84-9
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of NAD+:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) NAD+

More
Customer Validation & Images
Cell Proliferation/Viability AssayIPRT-PCRWBIF
  • Cell Proliferation/Viability Assay
  • RT-PCR
  • WB
  • WB
  • WB
  • IP
  • IF
  • IF

Ver todos los productos específicos de isoformas Endogenous Metabolite

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • NAD+ Chemical Structure
    NAD+ Chemical Structure
    1/16
  • 1/16

    NAD+ purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Feb:69:103030. [Abstract]

    Customer Validation
     LDH release assay showed the glioma cell death caused by SRT2183 (40 μmol/L) at 24 h was attenuated when the cells were pretreated 1 h with EX527 (200 μmol/L) or supplemented with exogenous NAD+ (2 mmol/L).

  • 1/16

    NAD+ purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Feb:69:103030. [Abstract]

    Customer Validation
     The declines of cysteine induced by SRT2183 (40 μmol/L) at 24 h were both suppressed by pretreating the cells 1 h with EX527 or supplementing exogenous NAD+ (2 mmol/L).

  • 1/16

    NAD+ purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Feb:69:103030. [Abstract]

    Customer Validation
     Western blotting revealed RSL3-induced downregulation of SLC7A11 and GPX4 was enhanced by FK866, but attenuated by exogenous NAD+ (2 mmol/L) supplement.

  • 1/16

    NAD+ purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Feb:69:103030. [Abstract]

    Customer Validation
     Pretreatment with FK866 (500 μmol/L) or supplement of exogenous NAD+ at 2 mmol/L for 1 h prevented RSL3-induced upregulation of ATF3 in both cytoplasmic and nuclear fractions.

  • 1/16

    NAD+ purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Feb:69:103030. [Abstract]

    Customer Validation
     Supplement of exogenous NAD+ at 1 mmol/L could inhibit ATF3 upregulation in the cells treated with FK866 (500 μmol/L) for 24 h, and this inhibition became more apparent by increasing NAD+ dosage to 2 mmol/L.

  • 1/16

    NAD+ purchased from MedChemExpress. Usage Cited in: Acta Pharmacol Sin. 2023 Oct;44(10):2125-2138. [Abstract]

    Customer Validation
     Western blotting proved supplement of exterior NAD+ (0.5-2 mmol/L, 1 h) dosage-dependently alleviated DPT-induced downregulation of phospho-AKT and upregulation of NOX2, NAT10, phospho-CREB, PARP1, and PAR.

  • 1/16

    NAD+ purchased from MedChemExpress. Usage Cited in: Vascul Pharmacol. 2022 Dec:147:107126. [Abstract]

    Customer Validation
     NAD+ significantly improves the expression of CD31 in the MI mice and DM + MI mice.

  • 1/16

    NAD+ purchased from MedChemExpress. Usage Cited in: Vascul Pharmacol. 2022 Dec:147:107126. [Abstract]

    Customer Validation
     NAD+ significantly improves the expression of VEGF in the MI mice and DM + MI mice.

  • NAD+